A new study describes a new personalized DNA-based digital assay that detects persistent chronic myeloid leukemia in 81 percent of samples taken from a group of patients thought to be in remission.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1K5nle2
No comments:
Post a Comment